You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and Zogenix undertakes no obligation to revise or update this release to reflect events or circumstances after the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.
SUMAVEL ®, DosePro ®, Relday TM and Zohydro TM ER are trademarks of Zogenix, Inc.
SABER ® is a trademark of DURECT Corporation.
CONTACT: Investor Contact Zack Kubow | The Ruth Group 646.536.7020 | email@example.com Media Contact Caitlin Cox | The Ruth Group 646.536.7033 | firstname.lastname@example.org